tiprankstipranks

Lewis Williams Insider Profile

4 Followers
Lewis Williams, Director at Five Prime Therapeutics, holds 455.34K shares in Five Prime Therapeutics (Ticker: FPRX), holds ― shares in Protagonist Therapeutics (Ticker: PTGX), holds ― shares in Neurogene (Ticker: NGNE).
tipranks
Lewis Williams

Lewis Williams
Five Prime Therapeutics (FPRX)
Director

Ranked #84,908 out of 98,743 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-40.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$110M
100.00%
0.00%
0.00%
A breakdown of Lewis Williams's holdings

Insider Roles

Arcellx Inc
(ACLX)
Director
Protagonist Therapeutics
(PTGX)
Director
Neurogene
(NGNE)
Director
Roles that Lewis Williams holds in companies

Most Profitable Insider Trade

Stock:
Five Prime Therapeutics
(FPRX)
Rating:Informative Buy
Date:May 13, 2016 - May 13, 2017
Return:-26.80%
The most profitable trade made by Lewis Williams

Lewis Williams's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FPRX
Five Prime Therapeutics
Sep 04, 2019
Uninformative Sell
38.14K
$17.30M
Protagonist Therapeutics
Director
Neurogene
Director
Arcellx Inc
Feb 09, 2022
Director
Uninformative Buy
$109.83M
List of latest transactions for each holding click on a transaction to see Lewis Williams's performance on stock

Lewis Williams insider profile FAQ

What is the percentage of profitable transactions made by Lewis Williams?
The percentage of profitable transactions made by Lewis Williams is 0%.
    What is the average return per transaction made by Lewis Williams?
    The average return per transaction made by Lewis Williams is -40.80%.
      What stocks does Lewis Williams hold?
      Lewis Williams holds: FPRX, PTGX, NGNE, ACLX stocks.
        What was Lewis Williams’s latest transaction?
        Lewis Williams latest transaction was an Uninformative Sell of $38.14K.
          What was Lewis Williams's most profitable transaction?
          Lewis Williams’s most profitable transaction was an Informative Buy of FPRX stock on May 13, 2016. The return on the trade was -26.80%.
            What is Lewis Williams's role in Five Prime Therapeutics?
            Lewis Williams's role in Five Prime Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.